However, recent studies have shown that genes repressed by TP53 are also key players in the tumor-suppressive effect of TP53. Within this latter aspect is the downregulation of cell-cycle genes via the p53–WAF1–DREAM–E2F/CHR pathway (p53–DREAM pathway). Here, CDKN1A is linked to neoplasm.